Page last updated: 2024-08-21

cyclopentane and Liver Dysfunction

cyclopentane has been researched along with Liver Dysfunction in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Aspichueta, P; Azkargorta, M; Banales, JM; Bujanda, L; Caballero-Camino, FJ; Drenth, JPH; Elortza, F; Izquierdo-Sanchez, L; Lee-Law, PY; Martinez-Chantar, ML; Marzioni, M; Olaizola, P; Perugorria, MJ; Rodrigues, PM1

Other Studies

1 other study(ies) available for cyclopentane and Liver Dysfunction

ArticleYear
Inhibition of NAE-dependent protein hyper-NEDDylation in cystic cholangiocytes halts cystogenesis in experimental models of polycystic liver disease.
    United European gastroenterology journal, 2021, Volume: 9, Issue:7

    Topics: Animals; Apoptosis; Bile Ducts; Cell Proliferation; Cell Survival; Cyclopentanes; Cysts; Enzyme Inhibitors; Humans; Liver Diseases; NEDD8 Protein; Protein Processing, Post-Translational; Pyrimidines; Rats; Sumoylation; Ubiquitin-Activating Enzymes; Ubiquitin-Conjugating Enzymes; Up-Regulation

2021